ACTG vs TECH · rev $285.2M vs P/E 65, rev $1.22B
Acacia Research Corporation (ACTG) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Acacia Research Corporation (ACTG) is a business equipment & supplies company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ACTG revenue for 2025-12-31 was $285.2M. Net income was $21.7M. Revenue was up 133.2% from 2024-12-31 to 2025-12-31. ACTG currently screens at market cap $452.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ACTG currently screens at market cap $452.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ACTG and TECH stock pages for the full models.
Not investment advice.